
Opinion|Videos|November 15, 2024
Adverse Event Management: Amivantamab
Author(s)Hatim Husain, MD
Hatim Husain, MD, discusses how the implementation of proactive prophylaxis strategies for patients taking amivantamab, including prophylactic antibiotics, good skin hygiene, and insights from the phase 2 COCOON study, can help manage potential adverse effects and improve treatment outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What proactive prophylaxis strategies have you integrated into your practice for patients taking amivantamab?
- Prophylactic antibiotics
- Good skin hygiene
- Phase 2 COCOON study findings
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Priority Review to Dato-DXd First-Line Metastatic TNBC
2
Dr Shubham Pant Highlights Progress and Promise in Pancreatic Cancer Treatment
3
FDA Accepts NDA of Zanzalintinib Combo for Pretreated Metastatic CRC
4
New Phase 2 Study of Tri-Modal Immunotherapy for Indolent B-Cell Lymphoma Launches
5




















